Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As markets wobble in 2026, investors are turning to a core portfolio cornerstone built on durable, recurring revenue....
Five AI models were asked whether Bitcoin would top $100,000 again in 2026. Four forecast a rebound above that level,...
Jeff Bezos reveals a bold new venture positioned to accelerate invention cycles and expand global prosperity, challen...
As geopolitical tensions flare, investors ask whether they should sell avoid) conflict XRP. This guide breaks down ri...
When the Fed signals a path to price stability, Bitcoin often takes a hit before buyers step in. This article breaks ...
Goldman Sachs has quietly built a $154 million stake in spot XRP ETFs, making it the largest disclosed holder as XRP ...
Strategy’s STRC slid to a new all-time low, closing at $89 after a session low of $88.51. Options traders are buildin...
As AI workloads surge, hyperscalers turn to ASICs to cut costs. This deep dive compares Broadcom and Marvell, explain...
SpaceX captures imagination and investors. But before you rush to buy, weigh the risks, liquidity, and market dynamic...
As markets swing in May 2026, a fresh analysis shows how cutting costs can undermine long-term investing. Here are ei...
Even a $2 million retirement portfolio rarely funds lavish withdrawals once taxes and healthcare costs are tallied. T...